Table 1.
Chloroquine dosage regimens currently in use. Dosing scenarios indicated by an asterisk (*) were explored in simulations.
| No | Dosing scheme | Indication | Reference |
|---|---|---|---|
| 1* | Adults: 500 mg × 2 for no more than 10 days | COVID-19 | Wong et al., 2020 |
| 2 | Adults: 500 mg × 2 for no more than 7 days A lower dose for patients weighing less than 50 kg |
COVID-19 | Wong et al., 2020 |
| 3* | Adults: At first 1000 mg once a day, then 500 mg 6 to 8 h after the first dose and then 500 mg on the second and third day of treatment Children and adults with low body weight: At first 10 mg/kg, then 5 mg/kg taken 6 h, 24 h, and 36 h after the first dose |
Malaria | Mayo Clinic, 2020 |
| 4* | Adults: 1000 mg once a day taken for 2 days. This is followed by 500 mg once a day for at least 2 to 3 weeks | Treatment of liver infection caused by protozoa | Mayo Clinic, 2020 |
| 5* | Adults, including pregnant women, and children: Total dose 25 mg/kg given over 3 days as follows: Day 1: 10 mg/kg, followed by 5 mg/kg 6–8 h later [this is equivalent for a 70 kg adult to: (700 + 350)*1.613 = 1,693 mg for the first day] Days 2 and 3: 5 mg/kg in a single dose [i.e. 350 mg for a 70Kg adult] (Since, dosages above are described in terms of chloroquine base, a conversion factor of 1.613 is used for converting to chloroquine phosphate) |
Parasitic diseases | WHO, 2020 |
| 6* | 500 mg daily for 2–10 days. It is also suggested the potential of a loading dose of 1 g | COVID-19 | Avdic, 2020 |
| 7 |
Treatment: 1000 mg once, then 500 mg at 6 h, 24 h and 48 h Prophylaxis (in chloroquine-sensitive regions): 500 mg (300 mg base) starting one week prior to entry, continue once weekly and then four weeks after leaving the endemic region |
Malaria | Avdic, 2020 |
| 8 | Days 1 and 2: 1000 mg/daily, From Day 3: 500 mg for 12 days | COVID-19 | Cortegiani et al., 2020 |
| 9 | 150 mg chloroquine phosphate every 12 h, inhaled by atomization for one week | COVID-19 | Cortegiani et al., 2020 |
| 10 | Two tablets chloroquine twice daily | Mild and common COVID-19 pneumonia | Cortegiani et al., 2020 |
| 11 | Two tablets chloroquine phosphate twice daily | Critically ill COVID-19 pneumonia | Cortegiani et al., 2020 |
| 12 | 12.600 mg twice daily for 10 days versus 450 mg twice daily (Day 1) followed by 450 mg once daily, for 4 days | Critically ill COVID-19 pneumonia | Borba et al., 2020 |